Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
If your bipolar meds keep failing, pharmacogenetic testing may be your vital next step by revealing how your genes metabolize mood stabilizers, antipsychotics, and antidepressants, which can reduce trial and error and side effects, though it does not diagnose or guarantee a response.
There are several factors to consider, including who should get tested, which medicines have the strongest evidence, test quality and insurance, how doctors use the results, and urgent symptoms that need immediate care; see below to understand more.
If you're living with bipolar disorder and your medications don't seem to be working — or the side effects feel worse than the symptoms — you're not alone.
Finding the right treatment for bipolar disorder can take time. Mood stabilizers, antipsychotics, and antidepressants affect each person differently. What works well for one person may cause intolerable side effects or no improvement for another.
This is where genetic testing for bipolar medication may help.
Pharmacogenetic testing (sometimes called PGx testing) looks at how your genes influence the way your body processes certain medications. It doesn't diagnose bipolar disorder. Instead, it may help your doctor choose medications that are more likely to work for you — and less likely to cause side effects.
Let's break down what this means, what science says, and whether it could be your next best step.
Bipolar disorder is a complex brain condition involving mood instability, including episodes of mania, hypomania, and depression. Treatment often includes:
Even when prescribed correctly, medications may:
A major reason for these differences? Your genes.
Genetic testing for bipolar medication analyzes specific genes involved in:
Most pharmacogenetic tests focus on liver enzymes in the cytochrome P450 (CYP450) system, including:
These enzymes determine whether you are a:
If you metabolize a medication too quickly, it may seem like it's "not working." If you metabolize it too slowly, even a normal dose may feel overwhelming.
Pharmacogenetic testing is supported by growing research, especially in psychiatry.
Credible medical organizations such as:
recognize that certain gene-drug interactions are clinically meaningful.
Strongest evidence currently exists for:
For example:
However, it's important to be realistic:
Genetic testing is a tool, not a guarantee.
It does not:
But it can reduce guesswork.
You may want to speak with your doctor about genetic testing for bipolar medication if:
If you're not yet formally diagnosed but experiencing concerning mood symptoms, you can use a free AI-powered tool to assess your symptoms of Bipolar Disorder and gain clarity before your doctor's appointment.
It's just as important to understand limitations.
Genetic testing for bipolar medication does not:
Bipolar disorder is influenced by genetics, brain chemistry, environment, and life experience. Medication response is only one piece of the puzzle.
Pharmacogenetic testing is usually simple:
Results typically categorize medications as:
Your doctor may adjust:
When used appropriately, potential benefits include:
For people who have struggled for years, this information can feel validating. It may explain why previous treatments failed.
Before pursuing testing, consider:
Some insurance plans cover pharmacogenetic testing when medically justified. Others may not.
Not all commercial tests are equally supported by scientific evidence. Your psychiatrist can help select a clinically validated option.
Results should always be reviewed by a qualified healthcare professional. Raw data without medical guidance can be misleading.
Medication response still depends on:
Certain symptoms require immediate medical attention, regardless of genetic testing:
If you experience anything that feels life-threatening or dangerous, seek emergency care immediately.
Genetic testing is helpful — but safety always comes first.
Genetic testing for bipolar medication represents a shift toward precision psychiatry. Instead of one-size-fits-all prescribing, doctors can use biological insight to guide decisions.
However:
If your medications have repeatedly failed, this may be a reasonable next step to discuss with your psychiatrist.
If bipolar medications aren't working — or the side effects feel unbearable — you're not difficult, and you're not imagining it. Your biology may be playing a role.
Genetic testing for bipolar medication can:
Start by speaking openly with your doctor about your treatment history. Ask whether pharmacogenetic testing makes sense in your case.
If you're still unsure about your symptoms or need help organizing your concerns before your appointment, try this free Bipolar Disorder symptom checker to better understand what you're experiencing.
Most importantly:
If you are experiencing suicidal thoughts, severe mood swings, psychosis, or any symptom that feels dangerous, seek urgent medical care immediately and speak to a doctor right away.
You deserve treatment that works — and modern medicine is increasingly able to tailor it to you.
(References)
* Kim DD, Chen A, Lerer B. Pharmacogenomics of Bipolar Disorder: A Comprehensive Review. Pharmacogenomics. 2018 Nov;19(15):1179-1191. doi: 10.2217/pgs-2018-0097. Epub 2018 Oct 31. PMID: 30375369.
* Rybakowski JK. Pharmacogenomics of Lithium Treatment in Bipolar Disorder. Pharmaceuticals (Basel). 2020 Feb 28;13(3):39. doi: 10.3390/ph13030039. PMID: 32121307; PMCID: PMC7151040.
* Reif A, Rösler B, Fritzen S, Kittel-Schneider S. Pharmacogenomic Testing in Psychiatry: A Guide to Drug-Gene Interactions and Clinical Implementation. Front Pharmacol. 2021 Mar 19;12:649131. doi: 10.3389/fphar.2021.649131. PMID: 33815049; PMCID: PMC8019448.
* Sforzini L, Pisanu C, Manca E, Del Zompo M, Marrosu F, Bocchetta A, Squassina A. Precision Psychiatry in Bipolar Disorder. Front Psychiatry. 2021 Apr 22;12:658189. doi: 10.3389/fpsyt.2021.658189. PMID: 33967812; PMCID: PMC8097721.
* Maciukiewicz M, Maciukiewicz P, Ma Z, Gupta A, Lysyganicz M, Janda J, Skrzeszewska J, Feski-Muszyńska E, Kruk M, Samardzija M. Clinical Utility of Pharmacogenomic Testing for Psychiatric Disorders: A Systematic Review. Front Pharmacol. 2022 Jul 25;13:920836. doi: 10.3389/fphar.2022.920836. PMID: 35957388; PMCID: PMC9358249.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.